Strikingly, we observed a substantial increase in the expression of apoptotic markers (e.g., cleaved forms of caspase-3 and PARP) in GIST-T1R treated with combination of BGJ 398 and sunitinib (Figure 5A) or regorafenib (Figure 5B). This evidence concerns the gene CASP3 and gastrointestinal stromal tumor.